This page is part of the FHIR Specification v6.0.0-ballot1: Release 6 Ballot (1st Draft) (see Ballot Notes). The current version is 5.0.0. For a full list of available versions, see the Directory of published versions
Patient Care Work Group | Maturity Level: N/A | Standards Status: Informative | Compartments: No defined compartments |
This is the narrative for the resource. See also the XML, JSON or Turtle format. This example conforms to the profile ConditionDefinition.
Generated Narrative: ConditionDefinition
Resource ConditionDefinition "example"
StructureDefinition Work Group: pc
url: http://hl7.org/fhir/ConditionDefinition/example
identifier: id: #urn:oid:2.16.840.1.113883.4.642.25.1
name: Hyperlipidemia
title: Hyperlipidemia Status
status: draft
date: 2019-05-26T10:44:00+10:00
publisher: HL7 International / Patient Care
contact:
description: Hyperlipidemia Status
code: Hyperlipidemia (disorder) (SNOMED CT#55822004)
hasSeverity: false
hasBodySite: false
hasStage: false
definition: https://med.stanford.edu/content/dam/sm/cerc/documents/Hyperlipidemia%20Management%20Protocol.pdf
observation: http://example.org/fhir/ObservationDefinition/lipid-panel, http://example.org/fhir/ObservationDefinition/cholesterol, http://example.org/fhir/ObservationDefinition/triglyceride, http://example.org/fhir/ObservationDefinition/cholesterol-hdl, http://example.org/fhir/ObservationDefinition/cholesterol-ldl
Code |
Gemfibrozil (RxNorm#203151 "fenoldopam mesylate") |
Reference |
http://acme.com/fhir/PlanDefinition/fd0e32d8-2ebd-4211-9e50-8983efddc2c6 |
Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.